Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Proteasomal Inhibition for Patients With Mis-sense Mutated Dysferlin (Dysferlin)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01863004
Recruitment Status : Terminated (insufficient enrollment rate)
First Posted : May 27, 2013
Last Update Posted : September 21, 2017
Sponsor:
Information provided by (Responsible Party):
University Hospital, Basel, Switzerland